Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study-Reference-Cited by-同舟云学术

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study

Published:2018-05 Issue:5 Volume:68 Page:1018-1024
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lee Seung Bum,Park Gyung-Min,Lee Jong-Young,Lee Byung Uk,Park Jae Ho,Kim Byung Gyu,Jung Seok Won,Jeong In Du,Bang Sung-Jo,Shin Jung Woo,Park Neung Hwa,Yang Dong Hyun,Kang Joon-Won,Lim Tae-Hwan,Kim Hong-Kyu,Choe Jaewon,Lee Han Chu

Publisher

Elsevier BV

Subject

Hepatology

Reference34 articles.

1. Nonalcoholic fatty liver disease;Brunt;Nat Rev Dis Primers,2015

2. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015

3. Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis;Loria;Clin Sci (Lond),2008

4. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease;Luo;Eur J Gastroenterol Hepatol,2015

5. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?;Oni;Atherosclerosis,2013

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy;Metabolism;2024-11

2. Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach;European Cardiology Review;2024-06-19

3. Metabolic dysfunction–associated fatty liver disease is associated with the presence of coronary atherosclerotic plaques and plaque burden;Hellenic Journal of Cardiology;2024-06

4. Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis;Frontiers in Medicine;2024-03-28

5. Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis;Vascular Pharmacology;2024-03